alosetron has been researched along with Hearing Loss, Sensorineural in 1 studies
alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henney, JE | 1 |
1 other study available for alosetron and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
From the Food and Drug Administration.
Topics: Administration, Inhalation; Adult; Anti-Inflammatory Agents; Asthma; Budesonide; Carbolines; Child; | 2000 |